7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vascular Calcification D061205 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Widschwendter M et al. Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. 2015 EBioMedicine pmid:26629528
Rachner TD and Rauner M RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. 2015 EBioMedicine pmid:26629502
Gennaro G et al. Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. 2015 PLoS ONE pmid:26270535
Janda K et al. Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. 2015 BMC Nephrol pmid:26037625
Davenport C et al. The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. 2015 Eur. J. Endocrinol. pmid:26036811
Zhao L et al. Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. 2015 J. Nutr. Biochem. pmid:26239832
de Molon RS et al. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. 2015 J. Bone Miner. Res. pmid:25727550
Nagy V and Penninger JM The RANKL-RANK Story. 2015 Gerontology pmid:25720990
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874

Table of Content